A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
Scope of the Report:
This report focuses on the Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The worldwide market for Biologics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3442799-global-biologics-market-2018-by-manufacturers-regions-type
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Market Segment by Applications, can be divided into
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
Complete Report Details @ https://www.wiseguyreports.com/reports/3442799-global-biologics-market-2018-by-manufacturers-regions-type
Table Of Contents:
1 Market Overview
1.1 Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Vaccines
1.2.3 Recombinant Proteins
1.2.4 Antisense
1.2.5 RNAi
1.3 Market Analysis by Applications
1.3.1 Infectious Diseases
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Autoimmune Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly & Company
2.1.1 Business Overview
2.1.2 Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly & Company Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Samsung Biologics
2.2.1 Business Overview
2.2.2 Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Samsung Biologics Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 F Hoffman La Roche
2.3.1 Business Overview
2.3.2 Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F Hoffman La Roche Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celltrion
2.4.1 Business Overview
2.4.2 Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celltrion Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Addgene
2.5.1 Business Overview
2.5.2 Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Addgene Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Continued…….
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com